S

Structure Therapeutics Inc
NASDAQ:GPCR

Watchlist Manager
Structure Therapeutics Inc
NASDAQ:GPCR
Watchlist
Price: 66.74 USD -4.63%
Market Cap: 4B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of GPCR.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GPCR Intrinsic Value
Not Available
Base Case Scenario
Compare GPCR to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GPCR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Structure Therapeutics Inc

Current Assets 814m
Cash & Short-Term Investments 799m
Other Current Assets 15m
Non-Current Assets 18.1m
PP&E 11.5m
Other Non-Current Assets 6.6m
Current Liabilities 57.5m
Accounts Payable 17.8m
Accrued Liabilities 33.2m
Other Current Liabilities 6.6m
Non-Current Liabilities 4.6m
Other Non-Current Liabilities 4.6m
Efficiency

Free Cash Flow Analysis
Structure Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Structure Therapeutics Inc

Revenue
0 USD
Operating Expenses
-247.6m USD
Operating Income
-247.6m USD
Other Expenses
36.9m USD
Net Income
-210.7m USD
Fundamental Scores

GPCR Profitability Score
Profitability Due Diligence

Structure Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
hidden
Profitability
Score

Structure Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

GPCR Solvency Score
Solvency Due Diligence

Structure Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Structure Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GPCR Price Targets Summary
Structure Therapeutics Inc

Wall Street analysts forecast GPCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GPCR is 77.37 USD with a low forecast of 50.5 USD and a high forecast of 126 USD.

Lowest
Price Target
50.5 USD
24% Downside
Average
Price Target
77.37 USD
16% Upside
Highest
Price Target
126 USD
89% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Structure Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for GPCR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

GPCR Insider Trading
Buy and sell transactions by insiders

GPCR News

Other Videos